Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
09/12/2002 | WO2002070724A2 Method of preparing 2-deoxyribose 5-phosphate |
09/12/2002 | WO2002070722A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
09/12/2002 | WO2002070718A1 Dna encoding l-ribose isomerae and use thereof |
09/12/2002 | WO2002070717A2 Nitrile hydratase and a method for producing amides |
09/12/2002 | WO2002070714A1 Aminoketone asymmetric reductase and nucleic acid thereof |
09/12/2002 | WO2002070713A2 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
09/12/2002 | WO2002070712A2 Chitin deacetylase and method for producing the same |
09/12/2002 | WO2002070711A1 Vaccine |
09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
09/12/2002 | WO2002070701A2 Novel human gnrh receptor |
09/12/2002 | WO2002070700A1 Polynucleotide useful for modulating cancer cell proliferation |
09/12/2002 | WO2002070695A2 Tumor associated proteins |
09/12/2002 | WO2002070685A2 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene |
09/12/2002 | WO2002070683A2 Biological compositions for solid waste treatment |
09/12/2002 | WO2002070682A2 Methods and compositions for waste treatment |
09/12/2002 | WO2002070673A1 Concentration and lysis of adenovirus-infected cells in a single unit operations |
09/12/2002 | WO2002070670A1 Novel lactobacillus reuteri useful as probiotics |
09/12/2002 | WO2002070669A2 Secreted proteins |
09/12/2002 | WO2002070666A2 Compositions and methods for regulating autolytic processes in bacteria |
09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
09/12/2002 | WO2002069991A1 Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
09/12/2002 | WO2002063010A9 Method of producing recombinant antibodies against tumors |
09/12/2002 | WO2002052012A3 Sugar beet genes involved in stress tolerance |
09/12/2002 | WO2002033067A3 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |
09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
09/12/2002 | WO2002012465A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
09/12/2002 | WO2002012462A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
09/12/2002 | WO2001048147A9 Cell culture medium containing growth factors and l-glutamine |
09/12/2002 | WO2001038509A9 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
09/12/2002 | WO2001022833A9 Pigment-containing materials to be added to feeds |
09/12/2002 | WO2001004322A9 Nucleotide sequences which code for the opca gene |
09/12/2002 | WO2001002609A3 Method of identifying toxic agents using differential gene expression |
09/12/2002 | WO2000077182A9 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
09/12/2002 | WO2000069901A3 Proteins with insulin-like activity useful in the treatment of diabetes |
09/12/2002 | WO2000063435A3 Method of identifying toxic agents using differential gene expression |
09/12/2002 | US20020129404 CTR1 homologue from melon |
09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
09/12/2002 | US20020129385 Medthods for improving long-term memory storage and retrieval |
09/12/2002 | US20020128464 Nucleotide sequences coding enzymatic polypeptide for use in generating geetically engineered herbicide sensitive plants |
09/12/2002 | US20020128463 Polypeptide for use in the treatment and diagnosis of cancer and defects associated with fungal and parasitic infections |
09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
09/12/2002 | US20020128307 Tetramic acid-type compounds isolated from a CCR-5 active complex produced by fermentation under controlled conditions of a biologically pure culture of the microorganism, Chaetomium globosum Kunze |
09/12/2002 | US20020128250 Modulating the expression of a gene |
09/12/2002 | US20020128192 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits |
09/12/2002 | US20020128186 Antimicrobial polypeptide, nucleic acid, and methods of use |
09/12/2002 | US20020128166 Detergents comprising cellulases |
09/12/2002 | US20020127703 Method for decomposing polyesters containing aromatic moieties, a denier reduction method of fiber, and microorganism having activity of decomposing the polyester |
09/12/2002 | US20020127701 Method and apparatus for disruption of biological material |
09/12/2002 | US20020127700 Methods for improved diagnosis and treatment of mycobacterial infections |
09/12/2002 | US20020127699 Kit for use in the detection preferential micoroganisms in sample |
09/12/2002 | US20020127696 Nucleotide sequences coding polypeptides for use in the generation of preferential mucopolysaccharides |
09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
09/12/2002 | US20020127689 Novel human galectins |
09/12/2002 | US20020127688 Detecting modulators of enzymes associated with transcriptional activities; obtain cells, incubate with modulators, monitor adjustment in enzyme activities |
09/12/2002 | US20020127687 Genome DNA of bacterial symbiont of aphids |
09/12/2002 | US20020127682 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
09/12/2002 | US20020127679 Used in industrial production of (S)-4-halo-3-hydroxybutyrate ester |
09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
09/12/2002 | US20020127675 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
09/12/2002 | US20020127673 Nucleotide sequences coding protein for use in the treatment of crohn's disease |
09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
09/12/2002 | US20020127667 Process for producing and recovering erythritol from culture medium containing the same |
09/12/2002 | US20020127666 Useful for production of intermediates in the adipic acid biosynthetic pathway or for the production of related molecules |
09/12/2002 | US20020127664 Protein for use in the generation of bronchodilating agent, pesticides, fungicide, herbicides and for use in the treatment of diabetes |
09/12/2002 | US20020127663 Nucleotide sequences coding enzymatic polypeptide for use in human generation of amino acids for use in human therapeutics and animal nutrients |
09/12/2002 | US20020127653 Hematopoietic signaling factor |
09/12/2002 | US20020127648 Novel human C5a-like receptor |
09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
09/12/2002 | US20020127646 CD38 modulated chemotaxis |
09/12/2002 | US20020127644 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
09/12/2002 | US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics |
09/12/2002 | US20020127642 Porcine leptin protein, antisense and antibody |
09/12/2002 | US20020127641 Proteases from gram-positive organisms |
09/12/2002 | US20020127638 Human metabotropic glutamate receptor 7 subtypes |
09/12/2002 | US20020127621 KUZ, a novel family of metalloproteases |
09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
09/12/2002 | US20020127601 Detecting modulators of g-protein coupled receptor activity; obtain cell containing g-protein coupled receptor pathway, incubate with modulator, determine quantative and qualitative effect of modulator on receptor |
09/12/2002 | US20020127596 murF2 |
09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
09/12/2002 | US20020127571 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations |
09/12/2002 | US20020127557 Method for identification of cDNAs encoding signal peptides |
09/12/2002 | US20020127553 Apoptin-associating protein |
09/12/2002 | US20020127540 Detecting modulators of bone morphogenic activities; obtain cells, incubate with modulator, monitor expression of reporter molecules, compare to control |